Minimal Invasive Procedure for Myocardial Infarction (MIMI)
Patients Presenting With Acute STEMI Treated With Primary PCI : Comparison of the Impact of the MIMI Approach With a Conventional Strategy of Immediate Stenting
Sponsor: Centre Hospitalier Annecy Genevois
This PHASE3 trial investigates ST Elevation Myocardial Infarction and is currently completed. Centre Hospitalier Annecy Genevois leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Oct 2019 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Oct 2019 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jun 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Annecy Genevois
- University Hospital, Grenoble
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Annecy, France , Antony, France , Bastia, France , Bourg-en-Bresse, France , Cannes, France , Chambéry, France , Clermont-Ferrand, France , Dijon, France , Grenoble, France , Lille, France and 11 more locations